LCID
Lucid Group, Inc.
LCID offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
MGA
Magna International Inc.
MGA has a slight edge over LCID overall, supported by lower modeled downside and stronger modeled upside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MGA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
MGA's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
MGA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8.3x | $62.37 | — |
| Cheap | 10x | $27.49 | -56% |
| Fair | 15x | $39.61 | -36% |
| Current | 23x | $62.37 | — |
| Expensive | 27x | $72.35 | +16% |
Historical ranges are pointers, not guarantees.
MGA's PE is in its expensive range at 23x. If earnings grow as analysts expect, today's price would be 8.3x next year's earnings, in its cheap range.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
MGA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect MGA's earnings to grow and its profitability to improve, with its revenue holding steady.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
MGA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.53 | +179% |
| Q2 2026 | $2.70 | -37% |
| Q1 2026 | $2.38 | -41% |
| Q4 2025 | $2.95 | -16% |
| Q3 2025 | $3.66 | -2.1% |
| Q2 2025 | $4.26 | +24% |
| Q1 2025 | $4.00 | +14% |
| Q4 2024 | $3.51 | -17% |
| Q3 2024 | $3.74 | +3.6% |
MGA has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over MGA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
MGA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $10.7B | +0.7% |
| Q1 2026 | $10.2B | +1.7% |
| Q4 2025 | $11B | +3.6% |
| Q3 2025 | $10.5B | +1.8% |
| Q2 2025 | $10.6B | -3% |
| Q1 2025 | $10.1B | -8.2% |
| Q4 2024 | $10.6B | +1.7% |
| Q3 2024 | $10.3B | -3.8% |
MGA's revenue grew through 2023 and has held roughly level since: $10.7B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 5.6% | +0.7 points |
| Q1 2026 | 4.3% | +1.2 points |
| Q4 2025 | 6.8% | +1 points |
| Q3 2025 | 9.2% | +3.8 points |
| Q2 2025 | 4.9% | 0 points |
| Q1 2025 | 3.1% | -0.6 points |
| Q4 2024 | 5.8% | +0.8 points |
| Q3 2024 | 5.4% | +5.4 points |
MGA has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
MGA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $654M | +72% |
| Q1 2026 | $458M | +$649M |
| Q4 2025 | $1.5B | +21% |
| Q3 2025 | $645M | +157% |
| Q2 2025 | $381M | +61% |
| Q1 2025 | -$191M | +$41M |
| Q4 2024 | $1.2B | +89% |
| Q3 2024 | $251M | +74% |
MGA has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
MGA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.8% | -4.9M shares |
| 1 year | -3% | -8.5M shares |
| 3 years | -4.6% | -13.1M shares |
| 5 years | -10% | -30.4M shares |
| Available history | -12% | -37.5M shares |
MGA has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $465M |
| Q1 2026 | $440M |
| Q4 2025 | $86M |
| Q3 2025 | — |
| Q2 2025 | $961,376 |
| Q1 2025 | $51M |
| Q4 2024 | $202M |
| Q3 2024 | — |
MGA spent $991M buying back its own shares over the past year, about four times what it spent the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MGA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.5x | Healthy |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 1.6x | Healthy |
| Q2 2025 | 1.6x | Healthy |
| Q1 2025 | 1.6x | Healthy |
| Q4 2024 | 1.5x | Healthy |
| Q3 2024 | 1.9x | Healthy |
MGA's net debt is about 1.4 years of its operating earnings (EBITDA), down from 1.6 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
MGA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.9 | Neutral |
| Stochastic | 10.9 | Oversold |
MGA's weekly RSI is 47 (neutral) and its Stochastic is 11 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
MGA PE vs Consumer Cyclical Sector
| Metric | MGA | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 18x | 28% above |
| PE % | 70 | 47 | 23 pts above |
MGA is trading at 23x earnings, a 28% premium to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
MGA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $64.0 | 2.5% below |
| 20 week MA | $65.9 | 5.3% below |
| 50 week MA | $61.6 | 1.2% above |
| 100 week MA | $51.2 | 22% above |
| 200 week MA | $51.2 | 22% above |
MGA has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
MGA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $55.3 | $70.6 | +28% |
| 2021 | $70.6 | $79.5 | +13% |
| 2022 | $79.5 | $55.5 | -30% |
| 2023 | $55.5 | $59.1 | +6.5% |
| 2024 | $59.1 | $42.2 | -29% |
| 2025 | $42.2 | $54.0 | +28% |
| 2026 YTD | $54.0 | $62.4 | +16% |
MGA has the edge over LCID on returns for 2026, with the stronger performance.